GlassScriptPhysician profile
Vivekananda A Gonugunta
NPI 1336319623
$7,671.37
in general payments reported to CMS, 2019-2025
7 companies · $19.67 in 2025
The $19.67 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,503 · 2020: $15.44 · 2021: $1,697 · 2023: $2,288 · 2024: $1,148 · 2025: $19.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,707 · Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,707.22 |
| Food and Beverage | $748.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,503.08 | 2019 | |
| Microvention, INC. | $1,977.19 | 2023 | Web Aneurysm Embolization System |
| Medtronic, INC. | $1,677.02 | 2021-2025 | Unid_pass, Cd Horizon Spinal System, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Globus Medical, INC. | $1,205.47 | 2021-2023 | Creo 5.5 |
| Siemens Medical Solutions USA, INC. | $293.17 | 2021 | |
| Medtronic Vascular, INC. | $15.44 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivekananda Gonugunta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.